CNR2 and amyotrophic lateral sclerosis: In amyotrophic lateral sclerosis (ALS), it has been shown that CB2 reduces glial cytokinic release, while CB1 has an important role in preserving synaptic transmission, which is most useful in symptomatic upkeep.